News: Bayer AG (BAYRY.PK)

BAYRY.PK on OTC Markets Group

146.92USD
29 Jan 2015
Change (% chg)

$2.97 (+2.06%)
Prev Close
$143.95
Open
$145.57
Day's High
$147.19
Day's Low
$145.18
Volume
40,231
Avg. Vol
61,441
52-wk High
$150.63
52-wk Low
$124.36

Search Stocks
Select another date:

Tue, Jan 27 2015

BRIEF-Bayer study to evaluate Xarelto in stroke patients

* Bayer forms collaboration with academic and governmental institutions for global phase III study to evaluate Xarelto

Richter expects 40-50 mln euros annual sales of Bayer patch in 3-4 yrs

BUDAPEST, Jan 27 - Hungarian drugmaker Richter expects a contraceptive patch licensed from Bayer HealthCare to produce annual revenues worth 40-50 million euros in three to four years, Chief Executive Erik Bogsch told Reuters on Tuesday.

BRIEF-Bayer forms collaboration for Rivaroxaban study

* Bayer news release: Bayer forms collaboration with academic and governmental institutions for Rivaroxaban study in patients with a recent embolic stroke of undetermined source Source text for Eikon: Further company coverage:

BRIEF-Bayer receives recommendation in EU for new use of Aflibercept

* Says bayer receives recommendation for approval for new treatment option with aflibercept solution for injection in eu for the treatment of patients with visual impairment due to macular edema secondary to retinal vein occlusion (RVO) Further company coverage:

BRIEF-AS Roma transfers Tin Jedvaj to Bayer 04 Leverkusen

* Reported on Tuesday that it has signed a contract with Bayer 04 Leverkusen for definitive sale of rights to the player Tin Jedvaj

BRIEF-FDA approves Bayer's Gadavist for pediatric patients

* Says fda approves bayer's gadavist (gadobutrol) injection as first magnetic resonance contrast agent for pediatric patients less than 2 years of age Further company coverage: (Reporting By Thomas Atkins)

IPO bankers earn a merry Christmas with a bumper year: data

LONDON/HONG KONG - Bankers responsible for floating companies and selling new shares into the market will enjoy a well-earned rest this Christmas after their busiest year since 2007, having notched up business worth almost $865 billion in the last 12 months.

UPDATE 2-China officially approves imports of Bayer GMO soy variety

(Adds comments from Bayer's director of U.S. soybean operations)

China officially approves imports of Bayer GMO soybean variety

CHICAGO - China has officially approved imports of a genetically modified Bayer CropScience soybean variety after seven years of review, the company said on Friday, raising expectations that approval notices will come soon for other grains.

China officially approves imports of Bayer GMO soybean variety

CHICAGO, Dec 19 - China has officially approved imports of a genetically modified soybean variety developed by Bayer CropScience after seven years of review, the company said on Friday.

Select another date:

Press Releases

Search Stocks